United States - English - NLM (National Library of Medicine)

hf acquisition co llc, dba healthfirst - chromic chloride (unii: kb1pcr9dmw) (chromic cation - unii:x1n4508kf1) - chromium 4 mcg/ml (chromic chloride injection, usp) is indicated for use as a supplement to intravenous solutions given for tpn. administration helps to maintain chromium serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms. none known. none known.

United States - English - NLM (National Library of Medicine)

hospira, inc. - chromic chloride (unii: kb1pcr9dmw) (chromic cation - unii:x1n4508kf1) - chromium 4 mcg/ml (chromic chloride injection, usp) is indicated for use as a supplement to intravenous solutions given for tpn. administration helps to maintain chromium serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms. none known. none known.

United States - English - NLM (National Library of Medicine)

hospira, inc. - chromic chloride (unii: kb1pcr9dmw) (chromic cation - unii:x1n4508kf1) - chromium 4 mcg/ml (chromic chloride injection, usp) is indicated for use as a supplement to intravenous solutions given for tpn. administration helps to maintain chromium serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms. none known. none known.

Malta - English - Medicines Authority

fresenius kabi limited - chromic chloride; copper chloride; ferric chloride; manganese chloride; potassium iodide; sodium fluoride; sodium molybdate dihydrate; sodium selenite; zinc chloride - concentrate for solution for infusion - chromic chloride 5.33 µg/ml; copper chloride 0.10 mg; ferric chloride 0.54 mg; manganese chloride 19.8 µg; potassium iodide 16.6 µg; sodium fluoride 0.21 mg; sodium molybdate dihydrate 4.85 µg; sodium selenite 17.3 µg; zinc chloride 1.05 mg - blood substitutes and perfusion solutions

Malta - English - Medicines Authority

fresenius kabi italia s.r.l via camagre 41, 37063 isola della scala (vr) , italy - chromic chloride, copper chloride, ferric chloride, manganese chloride, potassium iodide, sodium fluoride, sodium molybdate, dihydrate, sodium selenite, zinc chloride - concentrate for solution for infusion - chromic chloride 5.33 µg/ml copper chloride 0.102 mg/ml ferric chloride 0.54 mg/ml manganese chloride 19.8 µg/ml potassium iodide 16.6 µg/ml sodium fluoride 0.21 mg/ml sodium molybdate dihydrate 4.85 µg/ml sodium selenite 17.3 µg/ml zinc chloride 1.05 mg/ml - blood substitutes and perfusion solutions

Malta - English - Medicines Authority

fresenius kabi limited cestrian court, eastgate way, manor park, runcorn, cheshire wa7 1nt, united kingdom - chromic chloride, potassium iodide, copper chloride, ferric chloride, zinc chloride, manganese chloride, sodium fluoride, sodium molybdate, sodium selenite - concentrate for solution for infusion - chromic chloride 5.33 µg potassium iodide 16.6 µg copper chloride 340 µg ferric chloride 544 µg zinc chloride 1.36 mg manganese chloride 99 µg sodium fluoride 210 µg sodium molybdate 4.85 µg sodium selenite 10.5 µg - blood substitutes and perfusion solutions

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - chromic chloride hexahydrate, quantity: 5.33 microgram/ml; ferric chloride hexahydrate, quantity: 540 microgram/ml; sodium selenite, quantity: 17.29 microgram/ml; sodium fluoride, quantity: 210 microgram/ml; cupric chloride dihydrate, quantity: 102.3 microgram/ml; potassium iodide, quantity: 16.6 microgram/ml; sodium molybdate dihydrate, quantity: 4.85 microgram/ml; manganese chloride tetrahydrate, quantity: 19.79 microgram/ml; zinc chloride, quantity: 1.05 mg/ml - injection, concentrated - excipient ingredients: water for injections; hydrochloric acid; xylitol - to meet basal to moderately increased requirements of trace elements in parenteral nutrition in adults, when either oral or enteral nutrition is inappropriate

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - chromic chloride (unii: kb1pcr9dmw) (chromic cation - unii:x1n4508kf1) - chromic cation 1 ug in 1 ml

United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - fluoxetine hydrochloride (unii: i9w7n6b1kj) (fluoxetine - unii:01k63sup8d) - fluoxetine 10 mg - fluoxetine capsules, usp are indicated for the treatment of premenstrual dysphoric disorder (pmdd). the efficacy of fluoxetine in the treatment of pmdd was established in three placebo-controlled trials (see clinical trials). the essential features of pmdd, according to the dsm-iv, include markedly depressed mood, anxiety or tension, affective lability, and persistent anger or irritability. other features include decreased interest in usual activities, difficulty concentrating, lack of energy, change in appetite or sleep, and feeling out of control. physical symptoms associated with pmdd include breast tenderness, headache, joint and muscle pain, bloating, and weight gain. these symptoms occur regularly during the luteal phase and remit within a few days following onset of menses; the disturbance markedly interferes with work or school or with usual social activities and relationships with others. in making the diagnosis, care should be taken to rule out other cyclical mood disorders that may be exacerbated b

Kenya - English - Pharmacy and Poisons Board

fresenius kabi south africa (pty) limited stand 7, growthpoint business park, 162 tonetti - chromic chloride hexahydrate, copper chloride… - concentrate for solution for infusion - chromic chloride hexahyd 53.3mcg,copper chloride… - electrolytes in combination with other drugs